Kontakt 2023, 25(3):165-172 | DOI: 10.32725/kont.2023.031

Quality of life in patients with multiple sclerosisNursing - Original article

Anna Hudáková *, Ľudmila Majerníková, Andrea Obročníková
University of Presov, Faculty of Health Care, Department of Nursing, Presov, Slovak Republic

Objective: Multiple sclerosis is characterized by a diverse clinical course and high disability of the disease. The aim of the study was to identify and analyse the quality of life of patients with multiple sclerosis.

Methods: The authors collected data using WHOQOL-BREF tool. The research sample consisted of 81.40% women and 18.60% men. In terms of age, the largest representation was recorded in persons aged 31-50 (56.98%). The research sample was divided into two groups: persons with a disease duration of up to 11 years (60.47%), and persons with a disease duration over 11 years (39.53%).

Results: We compared the research findings in each domain with the standard population Statistical significance was confirmed in the physical domain in the area of mobility (p = 0.002**). Pain and discomfort were perceived more positively in both groups (M = 2.54 and M = 2.93) than in the population standard (PN = 4.03). We confirmed the statistical significance of survival in the area of concentration (p = 0.045*). The availability of health services proved to be important (p = 0.027**) in the environmental field. When comparing both groups in terms of disease duration, statistical significance was confirmed in the health satisfaction domain (p = 0.049*).

Conclusion: Decreased ability to move independently represents the greatest correlation with decreased quality of life. For patients with multiple sclerosis, it is advisable to create checklists and rehabilitation programs to improve their quality of life.

Keywords: Duration of the disease; Multiple sclerosis; Population standard; Quality of life; Satisfaction with health
Grants and funding:

This contribution was created within the framework of the grant project KEGA: 002PU-4/2020: Proposal of a methodology for evaluating the quality of life of patients with multiple sclerosis.

Conflicts of interest:

The authors have no conflict of interest to declare.

Received: April 14, 2023; Revised: August 7, 2023; Accepted: August 29, 2023; Prepublished online: September 13, 2023; Published: September 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hudáková A, Majerníková Ľ, Obročníková A. Quality of life in patients with multiple sclerosis. Kontakt. 2023;25(3):165-172. doi: 10.32725/kont.2023.031.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amato MP, Zipoli V, Portaccio E (2006). Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 254(1-2): 41-46. DOI: 10.1016/j.jns.2005.08.019. Go to original source... Go to PubMed...
    2. Ascherio A, Munger KL, Simon, KC (2010). Vitamin D and multiple sclerosis. Lancet Neurol 9(6): 599-612. DOI: 10.1016/S1474-4422(10)70086-7. Go to original source... Go to PubMed...
    3. Donáth V (2017). Prvé príznaky sclerosis multiplex a význam včasnej liečby. Via pract 14(5): 240-242.
    4. Dragomirecká E, Bartoňová J (2006). Dotazník kvality života Světové zdravotnické organizace WHOQOL-BREF. Psychometrické vlastnosti a první zkušenosti s českou verzí. Psychiatrie 10(3): 144-149.
    5. Drulovic J, Basic-Kes V, Grgic S, Vojinovic S, Dincic E, Toncev G, et al. (2015). The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey. Pain Med 16(8): 1597-1602. DOI: 10.1111/pme.12731. Go to original source... Go to PubMed...
    6. Eliášová A, Majerníková Ľ, Hudáková A, Kaščáková M (2015). Self-help group and the quality of life of patients with multiple sclerosis - Pilot study. Cent Eur J Nurs Midwifery 6(4): 336-342. Go to original source...
    7. Elshebawy H, Fahmy EM, Elfayoumy NM, Abdelalim AM, Ismail RS (2021). Clinical predictors to cognitive impairment in multiple sclerosis patients. Egypt J Neurol Psychiatr Neurosurg 57(38). DOI: 10.1186/s41983-021-00292-6. Go to original source...
    8. GBD 2016 Multiple Sclerosis Collaborators (2019). Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(3): 269-285. DOI: 10.1016/S1474-4422(18)30443-5. Go to original source... Go to PubMed...
    9. Grossmann J, Sivák Š, Michalík J, Kantorová E, Kurča E (2017). Mnestické poruchy u pacientov so sclerosis multiplex. Psychiatr prax 18(1): 8-12.
    10. Gürkan MA, Gürkan FT (2018). Measurement of Pain in Multiple Sclerosis. Noro Psikiyatr Ars 55(Suppl. 1): S58-S62. DOI: 10.29399/npa.23336. Go to original source... Go to PubMed...
    11. Gurková E (2011). Hodnocení kvality života. Pro klinickou praxi a ošetřovatelský výzkum. Praha: Grada, 224 p.
    12. Havrdová E, et al. (2013). Roztroušená skleróza. Praha: Mladá fronta, 485 p.
    13. Heesen C, Bohm J, Reich C, Goebel M, Gold SM (2008). Patient perception of bodily Functions in multiple sclerosis: gaitand visual function are the most valuable. Mult Scler 14(7): 988-991. DOI: 10.1177/1352458508088916. Go to original source... Go to PubMed...
    14. Heine M, Verschuren O, Hoogervorst EL, van Munster E, Hacking HG, Visser-Meily A, et al. (2017). Does aerobic training alleviate fatigue and improve societal participation in patients with multiple sclerosis? A randomized controlled trial. Mult Scler 23(11): 1517-1526. DOI: 10.1177/1352458517696596. Go to original source... Go to PubMed...
    15. Hudáková A, Novotná Z, Németh F, Šuličová A (2016). Geriatrické syndrómy ako prediktory ošetrovateľstva v geriatrii. Prešov: Prešovská univerzita v Prešove, Fakulta zdravotníckych odborov, 192 p.
    16. Jankovičová N, Kurča E (2016). Možnosti včasného záchytu pacientov s diagnózou SM v ambulancii všeobecného lekára. Via pract 13(3): 119-124.
    17. Kakalacheva K, Lünemann JD (2011). Environmental triggers of multiple sclerosis. FEBS Lett 586(23): 3724-3729. DOI: 10.1016/j.febslet.2011.04.006. Go to original source... Go to PubMed...
    18. Kantorová E (2018). Typické prvotné príznaky sclerosis multiplex. Via pract 15(4): 194-198.
    19. Kantorová E, Kurča E, Michalik J (2012). Hodnotenie kvality života pacientov so sclerosis multiplex. Neurol praxi 13(4): 211-214.
    20. Kantorová E, Michalik J, Sivák Š, Nosáľ V, Kurča E (2014). Evokované potenciály v diagnostike a monitorovaní vývoja roztrúsenej sklerózy. Neurológia 9(1): 18-22.
    21. Kantorová E, Poláček H, Bittšanský M, Baranovičová E, Hnilicová P, Čierny D, et al. (2017). Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. Neurol Res 39(4): 323-330. DOI: 10.1080/01616412.2016.1275460. Go to original source... Go to PubMed...
    22. Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, et al. (2013). Incidence and prevalence of multiple sclerosis in Europe: A systematic review. BMC Neurol 26(13): 128. DOI: 10.1186/1471-2377-13-128. Go to original source... Go to PubMed...
    23. Klímová E (2020). Závažné infekcie komplikujúce liečbu sclerosis multiplex. Neurol Praxi 21(Suppl. C): 3-10. DOI: 10.36290/neu.2021.007. Go to original source...
    24. Majerníková Ľ (2022). Hodnotenie úrovne kvality života pacientov so sclerosis multiplex novou validizovanou metódou v Slovenskej populácii. Prešov, Prešovská univerzita v Prešove, Fakulta zdravotníckych odborov, 244 p.
    25. Mikulášiková G, Kačmárová M (2014). Subjektívne hodnotená kvalita života depresívnych pacientov [Subjective assessed of the quality of life in depressive patient]. Individual and Society 17(4): 36-45.
    26. O'Donnell S, Syoufi M, Jones W, Bennett K, Pelletier L (2017). Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders. Health Promot Chronic Dis Prev Can 37(5): 160-171. DOI: 10.24095/hpcdp.37.5.04. Go to original source... Go to PubMed...
    27. Patti F (2009). Cognitive impairment in multiple sclerosis. Multi Scler 15(1): 2-8. DOI: 10.1177/1352458508096684. Go to original source... Go to PubMed...
    28. Ramagopolan SV, Dobson R, Meier UC, Giovannoni G (2010). Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9(7): 727-739. DOI: 10.1016/s1474-4422(10)70094-6. Go to original source... Go to PubMed...
    29. Štourac P, Praksová P, Kontrová I, Hladíková M, Okácová I, Benešová Y (2011). Glatiramer acetát v léčbe atakovité roztroušené sklerózy mozkomíšní - klinická úcinnost a bezpečnostný profil. Cesk Slov Neurol N 74/107(4): 447-454.
    30. Vasanthaprasad V, Khurana V, Vadapalle S, Palace J, Adlard N (2022). Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil. BMC Neurol 22(1): 301. DOI: 10.1186/s12883-022-02820-0. Go to original source... Go to PubMed...
    31. Vítková M (2016). Kvalita života pacientov so sclerosis multiplex. Via pract 13(6): 248-250.

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content